Avrion Therapeutics develops precision gene therapies for neurological disorders.

Avrion Therapeutics

Viewport Meta

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

Google Analytics

Font Awesome

Global Site Tag

LetsEncrypt

DoubleClick.Net

Co-Founder and Chairperson of Advisory Board

Brian McCabe

Co-founder and Chairperson of Advisory Board

Switzerland Companies With Fewer Than 50 Employees (Top 10K)

Europe, Middle East, and Africa (EMEA) Startups Founded in 2020

Europe Therapeutics Companies

Europe Companies With Fewer Than 10 Employees (Top 10K)

Avrion Therapeutics is a precision Gene Therapies for Neurodegenerative Diseases.

Seed Round - Avrion Therapeutics

Allschwil

Basel-Landschaft

Switzerland

Europe

A gene therapy product targeting ALS, specifically forms linked to SOD1 aberrations, preparing for IND-enabling studies.

Targets genetically-linked neurological disorders by delivering gene sequences to specific cells in the central nervous system, enhancing therapeutic efficacy and safety.

Supports the identification of novel targets for neurodegenerative diseases, enabling cell-specific genetic manipulation within the brain and spinal cord.

Lebanon

Asia

Australia

Oceania

France

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 23, 2024 10:12 AM	6fc17ab5
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 23, 2024 10:12 AM	13cab7ba
crunchbase trigger	general	Nov 22, 2024 7:44 AM	4f3bbeee
crunchbase profile	general	Nov 23, 2024 3:36 AM	4d1905e1
li profile	general
translate crunchbase fundingrounds	general	Nov 23, 2024 4:49 AM	ad397be5
peers	general	Oct 23, 2024 10:12 AM	09a5edbb
news basic	general	Oct 23, 2024 10:12 AM	50ed1129
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

AVRI

COM:AVRIONTX

Avrion Therapeutics